Skip to main content
Top
Published in: Rheumatology International 11/2012

01-11-2012 | Short Communication

Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review

Authors: Zehra Isik Hasiloglu, Murat Asik, Burak Erer, Atilla Suleyman Dikici, Ayse Altintas, Sait Albayram

Published in: Rheumatology International | Issue 11/2012

Login to get access

Abstract

Rheumatoid meningitis is a rare and serious complication of rheumatoid arthritis (RA) with high mortality rate. Clinical importance of the disease is high because diagnosis is difficult, and the disease is treatable if diagnosed successfully. We present the clinical and cranial magnetic resonance imaging findings of 62-year-old female patient with RA who has been followed up for 4 years.
Literature
1.
go back to reference Yucel AE, Kart H, Aydin P et al (2001) Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide. Clin Rheumatol 20:136–139PubMedCrossRef Yucel AE, Kart H, Aydin P et al (2001) Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide. Clin Rheumatol 20:136–139PubMedCrossRef
2.
go back to reference Kato T, Hoshi K, Sekijima Y et al (2003) Rheumatoid meningitis: an autopsy report and review of the literature. Clin Rheumatol 22:475–480PubMedCrossRef Kato T, Hoshi K, Sekijima Y et al (2003) Rheumatoid meningitis: an autopsy report and review of the literature. Clin Rheumatol 22:475–480PubMedCrossRef
3.
go back to reference Bekkelund SI, Pierre-Jerome C, Husby G, Mellgren SI (1995) Quantitative cerebral MR in rheumatoid arthritis. Am J Neuroradiol 16:767–772PubMed Bekkelund SI, Pierre-Jerome C, Husby G, Mellgren SI (1995) Quantitative cerebral MR in rheumatoid arthritis. Am J Neuroradiol 16:767–772PubMed
4.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef
5.
go back to reference Jones SE, Belsley NA, McLoud TC, Mullins ME (2006) Rheumatoid meningitis: radiologic and pathologic correlation. Am J Roentgenol 186:1181–1183CrossRef Jones SE, Belsley NA, McLoud TC, Mullins ME (2006) Rheumatoid meningitis: radiologic and pathologic correlation. Am J Roentgenol 186:1181–1183CrossRef
6.
go back to reference Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthr Rheum 18:258–266CrossRef Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthr Rheum 18:258–266CrossRef
7.
go back to reference Cellerini M, Gabbrielli S, Maddali Bongi S, Cammelli D (2001) MRI of cerebral rheumatoid pachymeningitis: report of two cases with follow-up. Neuroradiology 43:147–150PubMedCrossRef Cellerini M, Gabbrielli S, Maddali Bongi S, Cammelli D (2001) MRI of cerebral rheumatoid pachymeningitis: report of two cases with follow-up. Neuroradiology 43:147–150PubMedCrossRef
8.
go back to reference Matsushima M, Yaguchi H, Niino M et al (2010) MRI and pathological findings of rheumatoid meningitis. J Clin Neurosci 17:129–132PubMedCrossRef Matsushima M, Yaguchi H, Niino M et al (2010) MRI and pathological findings of rheumatoid meningitis. J Clin Neurosci 17:129–132PubMedCrossRef
9.
go back to reference Ahmed M, Luggen M, Herman JH et al (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33:2344–2346PubMed Ahmed M, Luggen M, Herman JH et al (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33:2344–2346PubMed
10.
go back to reference Chou RC, Henson JW, Tian D et al (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65:1114–1116PubMedCrossRef Chou RC, Henson JW, Tian D et al (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65:1114–1116PubMedCrossRef
11.
go back to reference Chowdhry V, Kumar N, Lachance DH et al (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288PubMed Chowdhry V, Kumar N, Lachance DH et al (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288PubMed
12.
go back to reference Claassen J, Dwyer E, Maybaum S, Elkind MS (2006) Rheumatoid leptomeningitis after heart transplantation. Neurology 66:948–949PubMedCrossRef Claassen J, Dwyer E, Maybaum S, Elkind MS (2006) Rheumatoid leptomeningitis after heart transplantation. Neurology 66:948–949PubMedCrossRef
13.
go back to reference Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68:1079–1080PubMedCrossRef Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68:1079–1080PubMedCrossRef
15.
go back to reference Beck DO, Corbett JJ (1983) Seizures due to central nervous system rheumatoid meningovasculitis. Neurology 33:1058–1061PubMedCrossRef Beck DO, Corbett JJ (1983) Seizures due to central nervous system rheumatoid meningovasculitis. Neurology 33:1058–1061PubMedCrossRef
Metadata
Title
Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review
Authors
Zehra Isik Hasiloglu
Murat Asik
Burak Erer
Atilla Suleyman Dikici
Ayse Altintas
Sait Albayram
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2105-6

Other articles of this Issue 11/2012

Rheumatology International 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.